hCG is a hormone that mimics LH (luteinizing hormone), the signal your pituitary sends to the testes to make testosterone and sperm. Most men use it for one of three reasons: to keep their testicles working while on TRT (so they don't shrink and so they can still have kids), to restart their natural production after a cycle, or as a standalone testosterone-raising therapy when they want to avoid the dependency of full TRT.
In women, it's used clinically for fertility, mainly to trigger ovulation in IVF cycles or to support ovulation in women whose pituitaries aren't sending enough LH. It's not a daily wellness compound for women, it's a fertility tool.
Deep-dive
hCG is structurally almost identical to LH and binds the same receptor (the LH/hCG receptor) on Leydig cells in the testes and theca/granulosa cells in the ovaries. The key practical difference is half-life: LH clears in about 30 minutes, hCG sticks around for roughly 30 hours, with peak testosterone response 72-96 hours after a dose. That's why a single shot can drive several days of testicular activity, and why dosing is typically every other day or 2-3 times a week rather than daily.
Why it matters on TRT. Exogenous testosterone shuts down LH and FSH from the pituitary, which means the testes stop getting the "make testosterone and sperm" signal. Intratesticular testosterone (ITT), the testosterone concentration inside the testes, is normally about 100x higher than blood testosterone, and it has to stay that high for sperm production to work. On TRT alone, ITT crashes by around 94%, which is why up to 65% of men on TRT become azoospermic. The Leydig cells also stop being stimulated, which is why testicles shrink. Adding hCG keeps the LH signal going at the testicular level. The landmark dose-response study here is Coviello 2005, which showed 250 IU every other day kept ITT within 7% of baseline, and 500 IU every other day pushed ITT 26% above baseline. 125 IU was insufficient.
Restoring fertility. Low-dose hCG (500 IU every other day) given alongside TRT preserved sperm production in men who would otherwise have become azoospermic, with 9 out of 12 men attempting conception successfully achieving pregnancy during therapy. For men coming off anabolic steroids, hCG is a core part of recovery: a survey of 470 men found that post-cycle therapy involving hCG and SERMs reduced withdrawal symptoms, cravings to restart, and suicidal thoughts by roughly 50-60%. For men with hypogonadotropic hypogonadism trying to conceive, the standard regimen is hCG 1,500-2,000 IU 2-3 times weekly, sometimes with FSH added if hCG alone doesn't restore spermatogenesis within 4-6 months.
As monotherapy for low T. This is the more recent use case. A 2019 case series of 20 men with symptomatic hypogonadism and total T above 300 ng/dL (so they didn't formally qualify for TRT) found that hCG monotherapy raised testosterone by 49.9% on average, from 362 to 520 ng/dL. A larger 2022 study of 31 men on weekly hCG found 86% reported improvement in erectile function and 80% in libido, with no significant changes to estradiol, hematocrit, PSA, or HbA1c. A separate study of 28 men who switched from TRT to hCG monotherapy maintained their testosterone levels and actually saw hematocrit decrease, with no thromboembolic events. The picture that's emerging: hCG monotherapy works for a subset of men, particularly those with secondary hypogonadism (where the pituitary is the issue, not the testes), and it has a cleaner side-effect profile than full TRT for some markers.
Why some men prefer it over TRT. No need for an aromatase inhibitor in most cases (estradiol tends to stay stable at typical doses), no hematocrit climb, testicles stay full size, fertility preserved, and you can stop without a months-long recovery. The trade-offs: it's an injection (subcutaneous, typically 2-3x weekly), more expensive than testosterone esters, and the testosterone bump is more modest than what you'd get from straight TRT.
Women. In women, the LH/hCG receptor sits on the ovaries. Clinically, hCG is used as the trigger shot in IVF (a single high dose, usually 5,000-10,000 IU or 250 mcg of recombinant hCG, to mimic the LH surge that triggers ovulation), and in lower doses (around 1,500 IU every 3 days during the luteal phase) to support the corpus luteum and progesterone production after ovulation. A 2015 trial showed 125 IU daily during the luteal phase produced higher progesterone than standard exogenous progesterone support and stayed within physiological LH range. For women with hypothalamic hypogonadism (often from low body weight, overtraining, or stress-induced amenorrhoea), combined FSH plus hCG is the standard ovulation induction protocol when pulsatile GnRH isn't available. The main risk in women is ovarian hyperstimulation syndrome (OHSS), where the ovaries overrespond and leak fluid into the abdomen. This is mostly a concern at trigger-shot doses in IVF, not at the doses men typically use. hCG isn't used in women for general wellness, libido, or hormone optimisation, the use case is fertility.
Older men and limitations. hCG works by stimulating the testes, so it requires functional Leydig cells. In men with primary hypogonadism (testicular failure rather than pituitary failure), where LH is already elevated above 20 IU/L, hCG won't do much, the testes are already maxed out and not responding. It's also worth noting that long-term safety data is limited compared to TRT, most studies run 6-18 months. Theoretical concerns about LH receptor desensitisation with high-dose chronic use exist, but haven't been clearly demonstrated at typical TRT-adjunct doses.
Dosage:
- TRT adjunct (preserve testicular function and fertility): 250-500 IU subcutaneous, every other day, or 500 IU 2-3 times per week. 500 IU every other day is the most common protocol and the one most strongly supported by intratesticular testosterone data
- Monotherapy for low testosterone or hypogonadal symptoms: typically 1,500-2,000 IU subcutaneous, 2-3 times per week. The 2022 monotherapy study averaged around 1,500 IU per week split across doses
- Post-cycle / steroid recovery: 1,000-3,000 IU 2-3 times per week for 2-4 weeks, often paired with a SERM (clomiphene or tamoxifen) to drive FSH recovery. Some protocols start higher (3,000 IU every other day) for the first 2 weeks then taper
- Fertility induction in hypogonadotropic hypogonadism (men): 1,500-2,000 IU 2-3 times per week for at least 4-6 months. FSH (75 IU every other day) added if sperm production hasn't recovered
- Women, IVF trigger: single dose of 5,000-10,000 IU (or 250 mcg recombinant) timed by your fertility clinic. This is not a self-administered protocol, it's clinic-managed
- Women, luteal phase support: 1,500 IU every 3 days post-ovulation, or 125 IU daily, depending on protocol. Also clinic-managed
- Injection method: subcutaneous (in the belly fat or thigh) is standard for low/moderate doses. Intramuscular works equally well but is unnecessarily painful for routine dosing. Reconstituted hCG keeps in the fridge for about 30-60 days depending on the diluent
- Timing: most men split into 2-3 weekly injections to keep blood levels steady. With a 30-hour half-life, every-other-day dosing produces stable Leydig stimulation without the peak-and-trough swings of weekly dosing
Here's what you can expect:
If you're using it as a TRT adjunct, the main things you'll notice are testicles staying full size (or recovering size if they'd shrunk), and fertility being preserved if you check semen analysis. Subjective effects on libido, mood, or energy are variable, some men report a noticeable improvement when adding hCG to TRT, others notice nothing.
If you're using it as monotherapy for low T symptoms, expect a slow build over 4-12 weeks. Testosterone climbs gradually, and the men who respond tend to report improved libido, morning erections, and energy in that window. Around half of monotherapy users report meaningful symptom improvement, the other half don't, particularly if their underlying issue isn't a true secondary hypogonadism.
If you're using it for post-cycle recovery, the goal is functional rather than felt, you're trying to restart your HPG axis. Testicles re-engage within 1-2 weeks, but full recovery of natural production after stopping hCG (and SERMs) typically takes 1-3 months. Severe or prolonged suppression can take 6+ months or sometimes never fully recover.
What hCG won't do: it won't get your testosterone to the supraphysiological levels of TRT or AAS. It works within the natural ceiling of your testicles' capacity. If your testes are damaged or unresponsive, hCG won't fix that, you need exogenous testosterone instead.
Side effects & risks:
- Estradiol elevation and gynecomastia. Because hCG drives testosterone production directly inside the testes, some of that testosterone aromatizes to estradiol locally. At low doses (250-500 IU EOD on TRT) the estradiol bump is usually clinically insignificant, but at higher doses (1,500+ IU per dose, or post-cycle protocols) estradiol can climb and breast tissue tenderness or growth can develop. Gynecomastia from hCG can be permanent if the tissue actually grows, soft tenderness is reversible but firm nodules often aren't. Manage with dose adjustment first, an aromatase inhibitor only if needed
- Acne, oily skin, mood changes. Same mechanisms as TRT, more testosterone means more sebum and more aggressive emotional reactivity in some users. Usually settles within 4-6 weeks
- Hematocrit. Generally less of an issue than with TRT (some studies actually show HCT decreasing on hCG monotherapy), but still worth monitoring at higher doses
- Injection site reactions. Mild redness, soreness, or bruising. Subcutaneous injection is well-tolerated. Rotate sites
- Headaches, fatigue, water retention. Reported but uncommon at typical doses
- Blood clots. Rare but documented, mostly in people with existing clotting disorders or in the FDA-warned weight-loss diet context. Risk is low at standard fertility/TRT doses but worth flagging if you have a thrombotic history
- Ovarian hyperstimulation syndrome (women). Real risk at trigger-shot doses in IVF, particularly in women with PCOS or high follicle counts. Symptoms: severe abdominal pain, bloating, nausea, rapid weight gain. Requires immediate medical attention. Not relevant at the doses men use
- Allergic reactions. Rare but reported, particularly with urinary-derived hCG (vs recombinant). Anaphylaxis is exceedingly uncommon
- LH receptor desensitisation. Theoretical with chronic high doses. Cycling on/off or keeping doses moderate (under 500 IU per dose for ongoing TRT use) avoids this in practice
- Underlying contraindications: active prostate or breast cancer, untreated thrombophilia, uncontrolled cardiovascular disease, primary testicular failure (it just won't work). Pregnancy detection: hCG is what pregnancy tests detect, so if you're a man on hCG and your partner takes a home pregnancy test from your bathroom, results will be misleading
- Quality and sourcing. Pharmaceutical hCG (urinary-derived like Pregnyl, Novarel, or recombinant like Ovidrel) is well-characterised. Underground or research-chemical hCG varies wildly in actual potency and sterility. The hormone is fragile and degrades fast if not handled correctly. Get it from a legitimate source if at all possible
Blood markers
Total testosterone, free testosterone, estradiol (sensitive assay), LH, FSH, baseline before starting. These tell you whether you have primary or secondary hypogonadism (which determines whether hCG will work) and give you a reference for tracking response.
SHBG, baseline. Helps interpret free vs total testosterone, especially if you're on monotherapy and trying to gauge real response.
Hematocrit, hemoglobin, PSA, baseline and at 3 months. Less of a concern than on TRT but still worth tracking, particularly PSA in men over 40.
Semen analysis if fertility is the goal, baseline and at 3-4 months. This is the only reliable way to know if hCG is doing its job for sperm production. Recovery after AAS use can take longer, recheck at 6 months if still suboptimal.
Recheck at 6-8 weeks for testosterone, estradiol, LH (which should be suppressed if hCG is working through receptor occupancy at TRT-adjunct doses). After that, every 3-6 months on stable dosing.
Who actually needs full bloodwork: anyone using hCG as monotherapy or as a TRT adjunct long-term, and anyone running a post-cycle protocol. If you're doing a single IVF trigger or short-term clinic-managed fertility cycle, your prescribing doctor handles the labs. If you're on a TRT-adjunct protocol that you've been stable on for years with no symptoms, you can extend to annual checks.
hCG is a prescription medication in most countries.
Made with Bullet